Health ❯ Healthcare ❯ Drug Safety

Side Effects

Adverse Reactions Gastrointestinal Issues GLP-1 Drugs Ocular Issues Patient Dropout Rates Patient Warnings Clinical Study Results Patient Tolerance Differentiation Syndrome Clinical Trials Amyloid-Related Imaging Abnormalities Risks of Tirzepatida

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

The weekly shot could improve adherence by replacing daily injections with one dose.

Pfizer’s Monthly Obesity Shot Shows Mid-Stage Gains With Up to 12.3% Weight Loss

FDA Clears Enhertu-Perjeta Combo for First-Line HER2-Positive Metastatic Breast Cancer

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

Pumitamig Shows High Response in First-Line Small Cell Lung Cancer Phase 2